Equitable Holdings »

Protalix Biotherapeutics shares owned by Equitable Holdings

Quarter-by-quarter ownership of Protalix Biotherapeutics (PLX) shares owned by Equitable Holdings from 13F filings

Historical chart of Equitable Holdings investment in Protalix Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Protalix Biotherapeutics held by Equitable Holdings consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Protalix Biotherapeutics by Equitable Holdings

Quarter filed Position value Share count Share price at filing
2025-12-31 $20k 11k 1.80

More positions owned by Equitable Holdings

Spdr Series Trust State Street Spd (SPYG)
Ishares Tr Core S&p500 Etf (IVV)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Vanguard Index Fds Growth Etf (VUG)
Vanguard Scottsdale Fds Vng Rus1000grw (VONG)
Spdr Series Trust State Street Spd (SPYV)
Select Sector Spdr Tr State Street Tec (XLK)
Vanguard Index Fds Value Etf (VTV)
Ishares Tr Morningstar Grwt (ILCG)
Vanguard World Inf Tech Etf (VGT)
Apple (AAPL)
Ishares Tr Expnd Tec Sc Etf (IGM)
NVIDIA Corporation (NVDA)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Vanguard Index Fds S&p 500 Etf Shs (VOO)

View all positions for Equitable Holdings

Top funds holding Protalix Biotherapeutics

BlackRock
Opaleye Management
Renaissance Technologies
Northern Trust
Geode Capital Management
State Street Corporation
Stratos Wealth Partners
Vanguard Group
Jane Street
Goldman Sachs Group
UBS Group
Connor, Clark & Lunn Investment Management
Main Street Financial Solutions
Bank of New York Mellon
Bridgeway Capital Management

View all funds holding Protalix Biotherapeutics